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An Overview of 2-Styrylchromones: Natural Occurrence,
Synthesis, Reactivity and Biological Properties
Clementina M. M. Santos[a,b] and Artur M. S. Silva*[b]
Abstract: 2-Styrylchromones are a small class of oxygen-con-
taining heterocycles. Despite their sparse occurrence in nature,
several synthetic approaches have been developed in order to
synthesize a large variety of derivatives, possessing different
substituents in different positions of the main core. They are
also versatile building blocks in the synthesis of new hetero-
1. Introduction
4H-Chromen-4-ones, or simply chromones (cf. the A component
in structure 1, Figure 1), a well-known class of oxygenated
heterocyclic compounds, play an important role in nature due
to their recognized biological, pharmacological and biocidal
activities.[1–3] These effects of these naturally occurring com-
pounds, associated with the large variety of substituents and
positions in their skeleton, have resulted in strong demand over
the years for their isolation in large amounts, for the develop-
ment of efficient and eco-friendly routes for their synthesis, as
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cyclic systems and important intermediates in the search for
bioactive compounds. It is our intention in this review to give
a general overview on the natural occurrence, synthesis, reactiv-
ity and biological properties of 2-styrylchromones, which were
published up until 2016.
well as the pursuit of new and more strongly bioactive ana-
logues. Moreover, the chromone ring system is a valuable start-
ing material in many chemical reactions leading to the prepara-
tion of a wide variety of synthetic derivatives, some of them
used nowadays as therapeutic agents.[2,4] It is therefore the alli-
ance of chemistry and biological activities that forms the basis
of this review, dedicated to the versatility of a small group of
Figure 1. Structure and numbering system of 2-SC (1).
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chromones possessing a styryl moiety (B component in struc-
ture 1, Figure 1) at position 2 and known as 2-styrylchromones
1 [or (E)-2-styryl-4H-chromen-4-one, 2-SC, Figure 1]. Here we
cover the sparse natural occurrence, synthesis, reactivity and
biological profile of 2-styrylchromones in a a single and general
overview intended to highlight better the importance of this
small group of oxygen-containing heterocycles.
NMR spectroscopy has been the most powerful technique
used for the structural elucidation of 2-SCs. The configuration
and conformation of 2-SCs were established through the analy-
sis of their 1D and 2D NMR spectra. The vicinal coupling con-
stant (JHα,H) at about 15–17 Hz indicates a trans configuration
for the double bond in all known natural 2-SC derivatives and
almost all the synthetic derivatives.[5–7] In addition, NOE cross
peaks observed between H-α and H-3 and the absence of cross
peaks between H- and H-3 confirm that, in solution, parent 2-
SC (1) exists in a C2-Cα s-trans conformation. The delocalized
C2=C3,Cα=C doubly unsaturated carbonyl system implies that
the C2–Cα bond has a character between a single and a double
bond, preventing free rotation, and only the s-trans conforma-
tion was observed (Figure 2).[6] These data were also confirmed
by NOESY experiments with other substituted 2-SCs.[5,7–9]
Figure 2. Four possible conformers of 2-SC and NOE effect in the E-s-trans
conformer.
The X-ray crystal structure of hormothamnione triacetate[10]
corroborates the E configuration of the Cα=C double bond
and the s-trans conformation of the C2-Cα bond in the solid
state.
To simplify the manuscript, the E configuration of Cα=C and
the C2-Cα s-trans conformation of 2-SC is assumed unless the
appropriate stereochemistry is specifically mentioned.
2. Natural Occurrence of 2-Styrylchromones
2-SCs are scarce in nature. Thirty years after the isolation of the
first natural 2-SC – hormothamnione (2, Figure 3) – there is still
no report that confirms the isolation of the parent compound
1 from natural sources. Hormothamnione (2) was first isolated
in 1986, from a chloroform/methanol extract of cyanobacterium
Hormothamnion enteromorphoides collected on the north coast
of Puerto Rico.[10] Three years later, Gerwick revised the taxon-
omy of the material collected to the Cryptophycean alga Chry-
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sophaeum taylori and even isolated the new, closely related de-
rivative 6-desmethoxyhormotamnione (3, Figure 3).[11] Yoon
et al. obtained a new, less substituted natural 2-SC in the form
of 5-hydroxylated derivative 4 (Figure 3), from the methanol
extract of the rhizomes of Imperata cylindrica.[12] The synthesis
of 4 and its structural elucidation by NMR spectroscopy have
been described previously by our group.[13] 6,4′-Dihydroxy-3′-
methoxy-2-styrylchromone (5, Figure 3) was isolated from the
ethanol extract of Chinese eaglewood as a yellow amorphous
solid and fully characterized by NMR, MS and IR spectro-
scopy.[14] In 2013, the five 5,7,4′-trihydroxy-2-styrylchromones
6–10 (Figure 3) were isolated from an ethanol extract of the
shed bark of Platanus x acerifolia.[15] Meanwhile, derivative 6
has also been isolated from heartwood of Juniperus chinensis
(by heating at reflux in methanol)[16] and from an ethanol ex-
tract of the bulbils of Dioscorea bulbifera.[17] It is also worth
noting that compound 6 was synthesized by us prior to its
isolation.[18] Of compounds 7–10, named platachromones A–D,
the prenylated analogue platachromone B (8) has recently been
synthesized by our group.[19]
Figure 3. Structures of natural 2-SC derivatives 2–10.
3. Synthesis of 2-Styrylchromones
As far as we know, the synthesis of 2-SCs goes back to 1923,[20]
and since then several approaches have been developed in or-
der to prepare a wide variety of analogues. These approaches,
also summarized in two previous papers,[21,22] include: (1) cycli-
zation of an acetylenic ketone, (2) Allan–Robinson condensa-
tion, (3) intramolecular Wittig reaction, (4) condensation of 2-
methylchromones with benzaldehydes, (5) aldol condensation
followed by oxidative cyclization, and (6) Baker–Venkataraman
rearrangement. It is our intention to describe these methodolo-
gies not chronologically but from the less frequently used to
the most widely used ones.
3.1. Cyclization of an Acetylenic Ketone
A simple attempt using an acetylenic ketone in the synthesis of
2-ST was reported. Only parent 2-SC (1) was prepared, in a mul-
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tistep strategy involving the treatment of tetrahydro-2H-pyr-
anyl-protected propargyl alcohol 11 with BuLi at –78 °C, addi-
tion of cinnamaldehyde, oxidation and removal of the protect-
ing group to afford the conjugated acetylenic ketone 12 in
81 % yield. Subsequent HBr-catalyzed cyclization in 1,4-dioxane
at 80 °C provided the unsubstituted 2-SC (1) in 82 % yield
(Scheme 1).[23]
Scheme 1. Synthesis of parent 2-SC (1) through cyclization of an acetylenic
ketone. THP = tetrahydro-2H-pyranyl, PPTS = pyridinium p-toluenesulfonate.
3.2. Allan–Robinson Condensation
The method developed by Allan and Robinson for the synthesis
of flavones was applied for the first time in the synthesis of 2-
SC in 1925. Heating appropriate cinnamic anhydrides and the
corresponding sodium cinnamates with 1-(2-hydroxyaryl)-2-
methoxyethan-1-ones at 180 °C led to the synthesis of a few 3-
methoxy-2-styrylchromones 13 (R2 = OMe, Scheme 2), which
after methyl cleavage provided the corresponding 3-hydroxy-2-
styrylchromones.[24] Years later other 3-unsubstituted (R2 = H)
and 3-methylated 13 (R2 = Me) derivatives were prepared by
using similar conditions in the condensation reaction
(Scheme 2).[25] The mechanism involves a one-step cinnamoyl-
ation of a 2′-hydroxyacetophenone, rearrangement to a 2-
cinnamoyl-2′-hydroxyacetophenone and cyclization.
Scheme 3. Synthesis of 2-SCs 18 through intramolecular Wittig reactions.
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Scheme 2. Synthesis of 2-SCs 13 through Allan–Robinson condensation.
3.3. Intramolecular Wittig Reaction
Only two publications have reported the synthesis of 2-SCs
through condensation of (2-hydroxybenzylidene)triphenylphos-
phoranes with cinnamoyl chloride. In the first one, 1-(2-
hydroxyphenacylidene)triphenylphosphorane (15, R1 = R2 =
R3 = H), prepared through the reaction between 2-acetoxy-
phenacyl bromide (14) and triphenylphosphine, followed by es-
ter hydrolysis, underwent condensation with cinnamoyl chlor-
ide in the presence of pyridine and toluene at reflux.[26] The
formed o-cinnamoyl ester 16 (R1 = R2 = R3 = H) underwent an
intramolecular Wittig reaction to give the parent 2-SC, in 65 %
yield. The second approach is a more general strategy and in-
volves reactions between [1-(2-hydroxybenzoyl)alkylidene]tri-
phenylphosphoranes 15 (obtained by condensation of methyl
2-hydroxybenzoates17withsubstitutedtriphenylphosphines)and
cinnamoyl chloride in dry pyridine at 60 °C for 24 h (Scheme 3).
A range of substituted 2-SCs 18 were prepared in 47–70 %
yields.[27]
3.4. Condensation between 2-Methylchromones and
Benzaldehydes
One of the oldest approaches to the synthesis of 2-SCs consists
of base-promoted condensation between 2-methylchromones
and benzaldehydes. In 1923, Heilbron et al. reported the first
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synthesis of various 3-methyl-2-styrylchromones 19 by conden-
sation of 2,3-dimethylchromone with a variety of substituted
benzaldehydes in the presence of sodium ethoxide in ethanol
at room temperature for 24 h (Scheme 4).[20] Naturally occurring
hormothamnione (2) was synthesized both by this strategy,[28]
and also in the presence of sodium methoxide in methanol
at reflux.[29,30] Under the latter conditions, some 3-methylated
and 3-unmethylated (2-styrylchromon-8-yl)acetic acids arose in
7–24 h in 40–55 % yields.[5] A couple of 3-bromo-2-styryl-
chromones 20 were prepared by condensation of 3-bromo-2-
methylchromone with benzaldehyde/4-benzyloxybenzaldehyde
in the presence of sodium methoxide in methanol at room tem-
perature, in good yields (Scheme 4).[31] Under the same reaction
conditions, the condensation of 2-methyl-3-styrylchromones
with parent benzaldehyde provided a few examples of 2,3-
distyrylchromones 21.[32] Condensation between 2-methyl-3-
Scheme 4. Synthesis of 2-SCs 19–23 through the condensation of 2-methyl-
chromones with benzaldehydes.
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nitrochromones and benzaldehydes in dry methanol at reflux
together with a few drops of piperidine afforded the corre-
sponding 3-nitro-2-styrylchromones 22 in 70–80 % yields.[33] A
wide range of 2-SCs 23, unsubstituted at C-3, were obtained
by condensation between substituted 2-methylchromones and
appropriate benzaldehydes in alkaline medium with ethanol as
solvent at room temperature,[25,34–36] 55 °C[37] or boiling tem-
perature[38] or even in methanol at reflux[39,40] (Scheme 4).
3.5. Aldol Condensation/Cyclodehydrogenation
A more general approach in the preparation of 2-SCs requires
an initial step in which a typical base-catalyzed aldol condensa-
tion between a 2′-hydroxyacetophenone and an appropriate
cinnamaldehyde affords the corresponding 2′-hydroxycinnam-
ylideneacetophenone 24. The reaction is usually carried out in
the presence of an aqueous solution of sodium hydroxide in
ethanol[25,41–43] or methanol[44,45] but the use of barium hydrox-
ide in ethanol[46–48] or methanol[49] and LiHMDS [lithium bis(tri-
methylsilyl)amide] in THF[50] has also been reported (Scheme 5).
These 2′-hydroxycinnamylideneacetophenones 24 undergo
cyclodehydrogenation to give the corresponding 2-SCs (E)-25
in the presence either of a catalytic amount of iodine in
DMSO[41,42,44–47,51–54] or of SeO2 in pentanol or xylenes.[55] Un-
der the former conditions, γ-substituted 2′-hydroxycinnamyl-
ideneacetophenones 24 afford not only the E isomers (E)-25
but also the Z isomers (Z)-25 in small amounts (11–15 % yields,
Scheme 5).[44,53]
It is noteworthy that Cheema et al. synthesized a few 2′-
hydroxycinnamylideneacetophenones that could not be con-
verted into 2-styrylchromanones either in boiling alcoholic
sulfuric acid or on prolonged contact with an alkaline solu-
tion.[25] Another interesting aspect is the reaction time in the
oxidative cyclization of 2′-benzyloxy-6′-hydroxycinnamyl-
ideneacetophenone 27 carried out in the presence of a catalytic
amount of iodine in DMSO (Scheme 6). Heating the reaction
mixture at reflux for 30 min led to the formation of the corre-
sponding 5-benzyloxy-2-styrylchromone (28) whereas on heat-
ing at reflux for 2 h, removal of the 5-benzyloxy group also
occurred and 5-hydroxy-2-styrylchromone (4) was isolated.[51,54]
Hydrogen iodide, formed during the cyclization step, reacts
with the benzyl group of the 2-SC to form benzyl iodide, which
undergoes oxidation promoted by DMSO to afford benz-
aldehyde and to regenerate hydrogen iodide to continue the
debenzylation process (Scheme 6). In the presence of one
equivalent of iodine or bromine, a subsequent electrophilic
substitution reaction occurs, with the corresponding 6,8-(diiodo
or dibromo)-5-hydroxy-2-styryl-chromones 29 being ob-
tained.[52] On the other hand, the presence of 0.5 equiv. of the
halogen led to a mixture of C-6 or C-8 monohalogenated 5-
hydroxy-2-styrylchromones 30 (Scheme 6).[54]
Other methodologies for preparing 3-hydroxy-2-styryl-
chromones 26 have also been developed, with 2′-hydroxy-
cinnamylideneacetophenones 23 being treated with hydrogen
peroxide in alkaline medium[43,49,50,55–58] or diethylamine in a
2:1 mixture of DMSO/1,4-dioxane[47] (Scheme 5). In these cases
pyranone ring closure occurs through an Algar–Flynn–Oyamada
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Scheme 5. Synthesis of 2-SCs 25–26 through aldol condensation between 2′-hydroxyacetophenones and cinnamaldehydes followed by cyclodehydrogenation
reactions. LiHMDS = lithium bis(trimethylsilyl)amide.
Scheme 6. Reaction behaviour of 2′-benzyloxy-6′-hydroxycinnamylidene-
acetophenone (27) in the presence of different amounts of iodine/bromine
in DMSO and reaction times.
(AFO) process. Although there is some controversy about the
mechanism of the AFO reaction[59–61] and the involvement or
not (pathways B and C) of epoxide formation (Scheme 7), we
can state that in the presence of base, cyclization of 2′-hydroxy-
cinnamylideneacetophenones 23 with simultaneous hydroxyl-
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ation promoted by hydrogen peroxide led to 3-hydroxy-2-
chromanones, which were subsequently oxidized to 3-hydroxy-
2-styrylchromones 26.
Scheme 7. Proposed mechanism for the Algar–Flynn–Oyamada (AFO) reac-
tion of chalcones.
3.6. Baker–Venkataraman Rearrangement
This is the most common and general method for the prepara-
tion of a large variety of 2-SCs. The classical approach involves
a three-step sequence: (i) condensation of appropriate 2′-
hydroxyacetophenones with cinnamoyl chlorides, (ii) base-pro-
moted Baker–Venkataraman rearrangement[62,63] of the formed
esters 31 into the 5-aryl-3-hydroxy-1-(2-hydroxyaryl)penta-2,4-
dien-1-ones 32 (in equilibrium with the corresponding diketone
form), and (iii) cyclodehydration to afford the desired 2-SCs 33
(Scheme 8). The cinnamoyl chlorides used in the esterification
step may be commercially available or can be prepared in situ
by treatment of the corresponding cinnamic acids with phos-
phoryl chloride in dry pyridine at room temperature or 60–
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90 °C[7,8,18,19,32,45,47,64–74] or with N,N-dicyclohexylcarbodiimide
(DCC) in the presence of a catalytic amount of 4-pyrrolidine-
pyridine (4-PPy) in dichloromethane at room temperature.[13,75]
Transposition of the cinnamoyl group from the 2′-position to
position 2 of the acetophenone occurs in the presence of
potassium hydroxide with DMSO[13,18,19,7,8,32,67–69,71,73] or pyr-
idine[47,64,70,73,74] as solvent, of sodium hydride in THF at re-
flux[8,45,65] or under less conventional conditions such as potas-
sium carbonate in acetone at reflux[66] or sodium hydroxide in
DMSO at room temperature.[75] The last step was originally
achieved in a strongly acidic medium (sulfuric acid in acetic
acid at reflux), but this is rarely used nowadays.[64,70,74] It has
been replaced by use of milder reagent systems, including the
use of a few drops of diluted hydrochloric acid in acetic acid,[73]
of p-toluenesulfonic acid (PTSA) in DMSO[13,18,19,7,8,65,67,68,72] or
of a catalytic amount of iodine in DMSO.[13,18,8,45,68] Individual
attempts with use of concentrated sulfuric acid in ethanol at
reflux,[66] grinding with phosphorus pentoxide under solvent-
free conditions[76] and with potassium carbonate in water under
classical heating at reflux or under microwave-assisted condi-
tions[77] have also been reported (Scheme 8).
Scheme 8. Three-step approaches to the synthesis of 2-SCs through Baker–Venkataraman rearrangement. DCC = N,N′-dicyclohexylcarbodiimide, 4-PPy = 4-
pyrrolidinepyridine, PTSA = p-toluenesulfonic acid, MW = microwave irradiation.
Scheme 9. Synthesis of 3-substituted 2-SCs 34 and 36 through cyclodehydration of the corresponding 5-aryl-3-hydroxy-1-(2-hydroxyaryl)penta-2,4-dien-1-
ones 32. PTT = phenyltrimethylammonium tribromide, NBS = N-bromosuccinimide.
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Nikam et al. performed a three-step approach to the synthe-
sis of 2-SCs and compared the use of classical heating condi-
tions and of ultrasound irradiation. The results indicate that
shorter reaction times and better yields are obtained with the
ultrasound-assisted method.[73]
The synthesis of 3-substituted 2-SCs by this three-step strat-
egy involves the previously mentioned penta-2,4-dien-1-ones.
Various 3-bromo-2-styrylchromones 34 were obtained when 5-
aryl-3-hydroxy-1-(2-hydroxyaryl)penta-2,4-dien-1-ones 32 were
treated with bromine in 1,4-dioxane[64] and with phenyltrimeth-
ylammonium tribromide (PTT) in THF at room temperature
(Scheme 9).[32,69] Treatment of penta-2,4-dien-1-ones with N-
bromosuccinimide (NBS) in CCl4 in the presence of benzoyl per-
oxide produces inseparable mixtures of 2-bromopenta-4-en-
1,3-diones 35 and 3-bromo-2-styrylchromones 34 (R3 = Br).
Cyclodehydration of the former compounds with sulfuric acid
in acetic acid gives solely 3-bromo-2-styrylchromones 34 (R3 =
Br). The isolation of 2-bromopenta-4-en-1,3-diones 35 was also
achieved when penta-2,4-dien-1-ones were treated with
bromine either in a 1:1 mixture of 1,4-dioxane/DMF or in acetic
acid in the presence of acetate buffer at room tempera-
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Scheme 10. Synthesis of 3-alkenyl-2-styrylchromones 37 and 38 through a multi-step approach starting from 2′-hydroxyacetophenone and cinnamoyl chlor-
ides. DBU = 1,8-diazabicyclo[5.4.0]undec-7-ene.
ture.[64,78] Moreover, treatment of penta-2,4-dien-1-ones 32
with sulfuryl chloride in 1,4-dioxane afforded 3-chloro-2-styryl-
chromones 34 (R3 = Cl) in good yields.[64] One-pot tandem reac-
tions between penta-2,4-dien-1-ones 32 and chromone-3-
carboxylic acid in the presence of a catalytic amount of 4-PPy
in chloroform at reflux provided a series of (2-hydroxyphenyl)-
3-oxoprop-1-enyl-2-styrylchromones 36 (Scheme 9).[75]
A unique multi-step approach allowed the preparation of a
few 3-alkenyl-2-styrylchromones 37 and 38 through DBU-pro-
moted condensation between 2′-hydroxyacetophenone and
cinnamoyl chlorides in acetonitrile, Baker–Venkataraman rear-
rangement with potassium tert-butoxide in THF to afford the
5-aryl-3-hydroxy-1-(2-hydroxyphenyl)penta-2,4-dien-1-ones 32,
acylation with Ac2O or (EtCO)2O in basic medium, reduction
with sodium borohydride in pyridine and finally dehydrative
rearrangement mediated by MeSO3H at room temperature
(Scheme 10).[79]
Two-step strategies involving Baker–Venkataraman rear-
rangement have appeared over the years. Makrandi and Kumari
reported condensation between 2′-hydroxyacetophenones and
cinnamic anhydrides in the presence of tetrabutylammonium
hydrogen sulfate in benzene/aqueous potassium carbonate bi-
phasic medium to give 5-aryl-3-hydroxy-1-(2-hydroxyaryl)penta-
2,4-dien-1-ones 32 directly; after cyclodehydration by treat-
ment with PTSA in DMSO these afforded the desired 2-SCs 33
in 65–80 % yields.[80] A similar procedure used cinnamoyl chlor-
ides in potassium carbonate/acetone medium, and cyclode-
hydration occurred in the presence of concentrated sulfuric acid
in ethanol at reflux (Scheme 11).[49,81]
The synthesis of 3-cinnamoyl-5-hydroxy-2-styrylchromones
40 was achieved through a two-step procedure involving the
condensation of 2′,6′-dihydroxyacetophenone with 2 equiv. of
appropriate cinnamic acids in the presence of DCC and 4-PPy
in dichloromethane at room temperature to afford the 2′,6′-
dicinnamoyloxyacetophenones 39, which underwent cyclo-
dehydration on treatment with potassium carbonate in dry pyr-
idine at 120 °C[13,82] or under MW irradiation[83] (Scheme 12).
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Scheme 11. Two-step approaches to the synthesis of 2-SCs 33 through Baker–
Venkataraman rearrangement. TBA = tetrabutylammonium.
Scheme 12. Synthesis of 3-cinnamoyloxy-2-styrylchromones 40 through a
two-step modified Baker–Venkataraman method.
A convenient one-pot synthesis of 3-cinnamoyl-5-hydroxy-7-
methyl-2-styrylchromones was accomplished when 2′,6′-di-
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hydroxy-4′-methylacetophenone was treated with 2 equiv. of
cinnamoyl chlorides in the presence of potassium carbonate in
acetone at reflux. The target 2-SCs were obtained in quantita-
tive yields on precipitation from the reaction medium, whereas
after purification by column chromatography the yields were
drastically decreased, due to crystallization during this proc-
ess.[84] On changing the acetophenone component to 2′,4′-di-
hydroxyacetophenone or 2′,4′,6′-trihydroxyacetophenone, 7-
cinnamoyloxy- or 5,7-dicinnamoyloxy-2-styrylchromones, re-
spectively, were obtained.[85]
4. Reactivity of 2-Styrylchromones
The reactivity of the 2-SC nucleus towards photooxidative reac-
tions, cycloadditions and nucleophilic addition reactions al-
lowed the synthesis of a series of heterocyclic compounds. In a
minor extension with the same goal, Heck reactions of 3-bromo
derivatives, reduction and epoxidation reactions have also been
performed.
4.1. Photooxidative Reactions
Photooxidative cyclization of 2-SCs 41 has been known since
1980, when Kumar et al. irradiated some derivatives in the pres-
Scheme 14. Synthesis of several tricyclic and tetracyclic compounds through photoirradiation of 2-SCs.
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ence of iodine in dry benzene, in quartz vessels, with a
medium-pressure mercury lamp for 50 h. This gave rise to
12H-benzo[a]xanthene-12-ones 42 in about 12 % yield
(Scheme 13).[86] One year later, a similar approach under air and
in the absence of iodine provided the same photoproducts in
shorter periods of time (15–20 h) and better yields (1–31 %
yield).[34] One of us reported the synthesis of other derivatives
Scheme 13. Synthesis of 12H-benzo[a]xanthen-12-ones 42 through photoirra-
diation of 2-SCs 41.
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through a more eco-friendly methodology using daylight irradi-
ation, chloroform as solvent and borosilicate glass vessels, in
good yields (50–60 %, Scheme 13).[44,53] These transformations
involve isomerization, cyclization and oxidation reactions, in
one-pot fashion.
Under photolytic conditions under nitrogen, (E)-3-benzyloxy-
6-methyl-2-styrylchromones 43, dissolved in benzene in a Pyrex
glass reactor, underwent isomerization and cyclization to afford
linear tricyclic tetrahydropyran[3,2-b]chromanones 44 in 20–
29 % yields.[87] Under similar conditions, 3-methoxy-6-methyl-2-
styrylchromone 45, dissolved in dry methanol, furnished a mix-
ture of the (Z)-2-SC (Z)-45, 3-demethoxylated 2-SC 46 and
oxetanochromanone 47. The introduction of a 3-allyloxy or 3-
prenyloxy group instead of a 3-methoxy group, in 2-SC 48, led
to a mixture of the two linear tricyclic photoproducts 49 and
51 and their angular counterpart 50 (Scheme 14).[43] A review
on the photochemistry of chromones and bischromones, which
includes the photoinduced H-abstraction from 2-SCs, has been
published.[88]
Irradiation of methanol solutions of (E)-3-hydroxy-2-(α-meth-
ylstyryl)chromones 52 with a mercury lamp led to mixtures
containing the corresponding Z isomers (Z)-52, linear tricyclic
9H-furo[3,2-b]chromen-9-ones 53 and angular fused tetracyclic
54 (Scheme 14).[89]
4.2. Cycloaddition
2-SCs can participate in a series of pericyclic reactions acting as
dienes or dienophiles, as well as dipolarophiles, to provide
other heterocyclic compounds. It was reported in 1954 that 2-
SCs act as dienes in Diels–Alder (DA) cycloaddition with maleic
anhydride (55, X = O) in boiling xylene, giving rise to the ex-
pected 3-aryl-1,2,3,9a-tetrahydro-9H-xanthen-9-one cycload-
ducts 56 (Scheme 15).[90] Similar reactions were carried out with
N-arylmaleimides (X = NAr1, Scheme 15),[91] dibenzoylethyl-
Scheme 15. 2-SCs as dienes in DA cycloaddition with maleic anhydride and
N-arylmaleimides.
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enes[92] and 1,4-benzoquinones[93,94] as dienophiles, and the
obtained cycloadducts were assumed also to be based on the
1,2,3,9a-tetrahydro-9H-xanthen-9-one moiety. However, studies
conducted by Letcher and Yue in 1992 on the reactivity of
2-SCs with maleic anhydride and with N-phenylmaleimide and
extensive spectroscopic characterization established that the
adduct structures were those of the isomeric 1,2,3,4-tetrahydro-
9H-xanthen-9-ones 57 (Scheme 15).[95,96] The formation of
these compounds 57 was the result of a [1,3] proton shift in
the formed adducts 56, with the driving force of this isomeriza-
tion being the stability of the reformed chromone moiety.
In addition, Letcher and Yue also studied the behaviour of
an electron-rich dienophile in DA cycloaddition with 2-SCs. Use
of one equimolar amount of the enamine 1-pyrrolidinylcyclo-
pentene (58) in 95 % ethanol at reflux led to the 1,2,3,4-tetra-
hydro-9H-xanthen-9-one cycloadducts 59 in 50–60 % yields
(Scheme 15).[97] The trans stereochemistry of the obtained
xanthones suggests that cycloaddition occurred through an
exo-DA addition with inverse electron demand.
Other pyrrolidine enamines, formed in situ from acetone,
butan-2-one and propanal in the presence of a catalytic amount
of pyrrolidine, underwent [4+2] cycloaddition with a variety of
2-SCs.[98] From acetone at reflux, several 3-aryl-1-methyl-9H-
xanthen-9-ones 60 were obtained as main products (56–76 %
yields, Scheme 16). 8-Methoxy-1-methylidene-3-phenyl-1,2,3,4-
tetrahydro-9H-xanthen-9-one (61) was also isolated as a single
minor product, which was converted into the corresponding
8-methoxy-1-methyl-3-phenyl-9H-xanthen-9-one (60, R1 = 5-
OMe) upon treatment with a mixture of acetic acid/sulfuric acid.
The mechanism involves formation of tetrahydroxanthones
through [4+2] inverse-electron-demand cycloaddition, migra-
tion of the exocyclic double bond and dehydrogenation of the
C-ring to yield the fully aromatized 1-methyl-9H-xanthen-9-
ones.
Two isomers were formed during pyrrolidine enamine prepa-
ration in situ from butan-2-one: 2-pyrrolidinobut-2-ene as the
major product and 2-pyrrolidinobut-1-ene as a minor compo-
nent. These underwent DA cycloaddition with 2-SCs to afford
3-aryl-2-methyl-1-methylidene-1,2,3,4-tetrahydro-9H-xanthen-
9-ones 62 (36–55 % yield) and small amounts of 3-aryl-1-ethyl-
9H-xanthen-9-ones 63 (13–16 % yield, Scheme 16). Treatment
of the former tetrahydro-9H-xanthen-9-one 62 (R1 = R2 = H)
with strong acid for 3 h led to the corresponding 1,2-dimethyl-
3-phenyl-9H-xanthen-9-one (64) in almost quantitative yield
(Scheme 16). An extension of this approach was applied to the
reaction between the pyrrolidine enamine of propanal and the
parent 2-SC, with the expected 2-methyl-3-phenyl-9H-xanthen-
9-one (65) being obtained in 12 % yield (Scheme 16).[98]
Acting as dienophiles, a series of 2-SCs reacted with excess
quantities of highly reactive o-benzoquinodimethane (66,
formed in situ by the thermal extrusion of sulfur dioxide from
1,3-dihydrobenzo[c]thiophene 2,2-dioxide) in 1,2,4-trichloro-
benzene at reflux to provide 2-(3-aryl-1,2,3,4-tetrahydronaphth-
2-yl)]chromones 67 (R1 = H) in 76–89 % yields (Scheme 17).[99]
Complete aromatization of the obtained cycloadducts was
achieved by a two-step approach involving benzylic bromin-
ation with NBS in the presence of benzoyl peroxide and subse-
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Scheme 16. 2-SCs as dienes in DA cycloaddition with pyrrolidine enamines.
quent dehydrobromination by heating the corresponding prod-
ucts in triethylamine at reflux. It is noteworthy that small
amounts of brominated naphthylchromones 69 (R1 = H) were
Scheme 17. 2-SCs as dienophiles in DA cycloaddition with symmetric o-benzoquinodimethanes. DDQ = 2,3-dichloro-5,6-dicyano-1,4-benzoquinone.
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also obtained and easily converted into the desired naphthyl-
chromones 68 (R1 = H) by treatment with ammonium formate
and Pd/C in methanol at reflux.
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To avoid the bromination step, o-benzoquinodibromodi-
methane (70), prepared in situ from α,α,α′,α′-tetrabromo-o-xyl-
ene, was allowed to react with 2-SCs in DMF at reflux; this also
afforded naphthylchromones 68 (R1 = H), in a one-pot reaction.
Complete aromatization of 1,2,3,4-tetrahydronaphthylchrom-
one 67 (R1, R3 = H, R2 = Me) derived from 2-(α-methylstyr-
yl)chromone was not possible; instead, 2-(2-methyl-3-phenyl-
1,2-dihydronaphth-2-yl)]chromone 71 was isolated in 78 %
yield.[99]
Years later, Silva's group extended the study to reactions be-
tween o-benzoquinodimethane (66) and 2-SCs substituted at C-
5. The corresponding 1,2,3,4-tetrahydronaphthylchromones 67
(R1 = OH) were prepared in lower yields (62–63 %). Subsequent
dehydrogenation was performed in one-pot fashion with 2,3-
dichloro-5,6-dicyano-1,4-benzoquinone (DDQ) as oxidant in 1,4-
dioxane or 1,2,4-trichlorobenzene at reflux under MW irradia-
tion (Scheme 17). Better yields and shorter reaction times were
accomplished in the MW-assisted reactions.[100]
DA cycloaddition between 2-SCs and asymmetric pyrimidine
o-quinodimethane 72, prepared in situ by thermal extrusion of
sulfur dioxide from 4-methoxy-2-methyl-5,7-dihydrothieno[3,4-
d]pyrimidine 6,6-dioxide, led to mixtures of regioisomeric
tetrahydroquinazoline-substituted chromones 73 and 74, with
2-(7-aryl-4-methoxy-2-methyl-5,6,7,8-tetrahydroquinazolin-6-yl)-
chromone derivatives 73 being the major isomers
(Scheme 18).[101] Variable amounts of the starting 2-SCs were
also recovered (5–45 %).
Scheme 18. 2-SCs as dienophiles in DA cycloaddition with asymmetric pyrim-
idine o-quinodimethane 72.
Scheme 19. 2-SCs as dipolarophiles in 1,3-cycloaddition with diazomethane.
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Studies involving 2-SCs as dipolarophiles in 1,3-cycloaddition
reactions with diazomethane or sodium azide have been re-
ported. Treatment of 2-SCs with diazomethane in chloroform/
diethyl ether 1:3 mixtures at room temperature gave access
mainly to 4-aryl-3-(chromon-2-yl)-2-pyrazolines 75 with higher
Rf values (68–92 % yields) and, with lower Rf values, the 3-aryl-
4-(chromon-2-yl)-1-pyrazoline regioisomers 76 (1–5 % yields,
Scheme 19).[65] Compounds 75 resulted from the isomerization
of the formed cycloadducts 77 due to the acidity of Ha
(Scheme 19).
The reactivity of the Cα=C double bond was also tested
when 2-SCs were brominated with pyridinium tribromide in
acetic acid at room temperature (Scheme 20). Mixtures of
3-bromo-2-styrylchromones 78, 2-(2-aryl-1,2-dibromoethyl)-
chromones 79 and 2-(2-aryl-1,2-dibromoethyl)-3-bromo-
chromones 80 were isolated, according to the substitution pat-
tern of the 2-SC. Dehydrobromination of 2-(2-aryl-1,2-di-
bromoethyl)chromones 79 with triethylamine in toluene at re-
Scheme 20. 2-SC derivatives as dipolarophiles in the 1,3-cycloaddition reac-
tions with sodium azide.
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flux gave both geometric isomers: (Z)-2-(α-bromostyryl)chrom-
ones (Z)-81 as major products and (E)-2-(α-bromostyryl)-
chromones (E)-81 as minor products. Independent treatment of
isomers (Z)-81 and (E)-81 with sodium azide (excess) in DMF at
reflux afforded mainly 4(5)-aryl-5(4)-chromon-2-yl-1,2,3-triazoles
82 (30–40 % yield) and 1-aryl-5-(chromon-2-ylmethyl)tetrazoles
83, in 10–12 % yields (Scheme 20).[102] Later on, the group im-
proved the protocol to include other (Z)-2-(α-bromostyryl)-
chromones (Z)-81 by increasing the amount of sodium azide
from 2 to 5 molar equivalents and decreasing the reaction tem-
perature from reflux to 120 °C for 24 h, with only 4(5)-aryl-
5(4)-chromon-2-yl-1,2,3-triazoles 82 being obtained, in 61–83 %
yields.[103] Similar procedures with 2-SCs and 2-(2-aryl-1,2-di-
bromoethyl)chromones 79 as starting materials led to the same
4(5)-aryl-5(4)-chromon-2-yl-1,2,3-triazoles 82 in 47–65 % and
54–73 % yields, respectively (Scheme 20).[103] These one-pot re-
actions showed that bromination and dehydrobromination
steps can be avoided in the preparation of 1,2,3-triazole deriva-
tives of this type.
4.3. Reactions with Nucleophiles
The most common transformation of 2-SCs involving 1,4-addi-
tion reactions involves the use of hydrazines in order to prepare
pyrazole derivatives. A series of (E)-3-(2-benzyloxy-6-hydroxy-
phenyl)-5-styrylpyrazoles 84 were thus obtained by treatment
of 5-benzyloxy-2-styrylchromones with hydrazine hydrate or
methylhydrazine in excess, in methanol at reflux for 24 h, in
moderate to good yields (Scheme 21).[104,105] The proposed
mechanism includes nucleophilic attack at C-2 of the 2-SC, ring
Scheme 21. 1,4-Addition reactions of hydrazine derivatives to 2-SCs.
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opening and intramolecular hydrazone formation. A detailed
investigation of the mother liquors from the reactions between
5-benzyloxy-2-styrylchromones and hydrazine hydrate in excess
found not only the expected (E)-3-(2-benzyloxy-6-hydroxy-
phenyl)-5-styrylpyrazoles 84, but also the 3-(2-benzyloxy-6-
hydroxyphenyl)-5-(2-phenylethyl)pyrazoles 85 and 5-aryl-
3-(2-benzyloxy-,6-dihydroxystyryl)-2-pyrazolines 86.[45] The
amounts of pyrazoles 84 increased with increasing amounts of
hydrazine and/or on heating at reflux longer than necessary for
the disappearance of the starting 2-SC. Reduction of the major
pyrazoles 84 induced by diazene (N2H2, formed by oxidation of
hydrazine) explains the formation of the minor pyrazoles 85. 2-
Pyrazolines 86 arise from nucleophilic attack at C-2 of the 2-SC,
ring opening and conjugate addition of hydrazine to C-γ of the
formed α,,γ,δ-doubly unsaturated opened system. A series of
new 5(4)-aryl-4(5)-[3(5)-(2-hydroxyphenyl)-1H-pyrazol-5(3)-yl]-
1H-1,2,3-triazoles 88 were prepared in moderate to good yields
by treatment of 5(4)-aryl-4(5)-(chromon-2-yl)-1H-1,2,3-triazoles
87 with hydrazine hydrate in excess (5 molar equivalents) in
methanol at 60 °C (Scheme 21).[106]
1,6-Conjugate additions of various nucleophiles to 2-SCs
have been reported in a couple of papers. Thus, treatment of
2-SCs with nitromethane in the presence of DBU at room tem-
perature afforded the corresponding 2-(2-aryl-3-nitromethyl)-
chromones 89 in moderate to good yields. Subsequent reduc-
tion with tin powder and hydrochloric acid provided 2-substi-
tuted 4-arylpyrrole derivatives 90 in better yields than achieved
with ammonium formate and Pd/C (Scheme 22).[107] On the
other hand, a domino multicomponent 1,6-/1,6-/1,4-conjugate
addition reaction between parent 2-SC (1) and nitromethane
occurs under phase-transfer catalysis to give a mixture of
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Scheme 22. Conjugate addition of nitromethane, ethyl malonate and malononitrile to 2-SCs. TBAB = tetrabutylammonium bromide.
Scheme 23. Microwave-assisted tandem reactions between 3-bromo-2-styrylchromones and 1-(prop-1-en-2-yl)pyrrolidine for the synthesis of cyclo-
hepta[b]chromene-9,11-diones 97 as major products.
pentasubstituted spirocyclohexanes 91 and 92 in poor yields
and with recovery of an 11 % yield of 2-SC (1, Scheme 22).[108]
2-SCs underwent 1,6-conjugate addition with ethyl malonate
in the presence of sodium ethoxide as base, giving rise to ad-
ducts 93 after 2–4 days, although in low yields (8–54 %). Use
of malononitrile as nucleophile in the presence of a catalytic
amount of piperidine in ethanol at reflux for 3–4 days afforded
-malononitrile adducts 94 (14–53 % yield) as major products,
together with the α-malononitrile derivatives 95 in poor yields
(2–23 %) (Scheme 22). In these reactions it was also possible to
recover some starting 2-SCs.[108]
The synthesis of cyclohepta[b]chromene-9,11-diones 96 oc-
curred through microwave-assisted tandem 1,6-conjugate addi-
tion/Michael-initiated ring closure reactions between 3-bromo-
2-styrylchromones and 1-(prop-1-en-2-yl)pyrrolidine, prepared
in situ from acetone and pyrrolidine, at 100 °C for 20 min.
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Subsequent acid-promoted cyclopropane ring-expansion led
mainly to cyclohepta[b]chromene-9,11-diones 97; small
amounts of benzofuran-4(5H)-ones 98 were also isolated
(Scheme 23).[109]
4.4. Miscellaneous Reactions
Many synthetic routes require the protection of substituents in
order to avoid the formation of by-products, to improve solubil-
ity in the reaction medium and to support the isolation and/
or purification processes. These protecting groups are usually
removed in the last step to allow the synthesis of the target
compounds. The most commonly used substituents for the pro-
tection of hydroxy groups in 2-SCs are the methyl and benzyl
groups. Thus, demethylation of methoxy-substituted 2-styryl-
chromones is achieved by treatment with boron tribromide in
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dry dichloromethane,[40] whereas debenzylation of benzyloxy-
substituted 2-styrylchromones occurs in the presence of
hydrogen bromine in acetic acid at reflux.[18,47] Simultaneous
demethylation and debenzylation was performed with use of
an excess of aluminium chloride and sodium iodide in dry
acetonitrile at room temperature for 12 h.[47] The cleavage of
cinnamoyl groups was achieved when 7-cinnamoyloxy- and 5,7-
dicinnamoyloxy-substituted 2-styrylchromones were hydro-
lyzed with 5 % methanolic potassium hydroxide at reflux for
30 min.[85] p-Methoxybenzyl cleavage was carried out in the
presence of trifluoroacetic acid in dichloromethane at room
temperature for 30 min.[37]
Boron tribromide also promoted simultaneous demethyl-
ation and cyclization of 3-cinnamoyl-5-hydroxy-2-styrylchrom-
ones, to afford (E)-3-aryl-4-benzylidene-8-hydroxy-3,4-dihydro-
1H-xanthene-1,9(2H)-diones 99,[83] and of 5,7-dimethoxy-8-
prenyl-2-styrylchromones to give (E)-5-hydroxy-8,8-dimethyl-
2-styryl-9,10-dihydropyrano[2,3-f ]chromen-4(8H)-ones 100[19]
(Scheme 24).
Scheme 24. Simultaneous demethylation and cyclization of 2-SCs promoted
by boron tribromide.
A series of 2-cinnamoyl-3(2H)-benzofuranones 101 were syn-
thesized when 3-bromo- and 3-chloro-2-styrylchromones un-
derwent rearrangement in the presence of potassium hydroxide
in ethanol at reflux (Scheme 25).[64] Reductive cyclization of
3-nitro-2-styrylchromones promoted by triethyl phosphite at
reflux for 9 h led to pyrrolo[3,2-b]chromones 102 in 45–50 %
yields (Scheme 25).[33]
Several 2-(2-phenylethyl)chromones were synthesized by se-
lective reduction of the double bond of the styryl group with
hydrogen and activated Pd/C in methanol at reflux[40] or by
addition of ammonium formate as hydrogen-transfer cata-
lyst.[110]
The conversion of 6-bromo-2-styrylchromones into 6-iodo-2-
styrylchromones involves a two-step approach based on a
bromo-to-tributyltin exchange reaction catalyzed by Pd0 and
subsequent treatment with iodine in chloroform. The tributyltin
intermediates can also undergo iododestannylation, in the pres-
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Scheme 25. Cyclization reactions of 3-substituted 2-SCs.
ence of hydrogen peroxide as oxidant, in order to prepare 6-
radioiodinated 2-SCs.[70,74]
A large variety of 2,3-diarylxanthones 103 result as major
products from reactions between polysubstituted 3-bromo-2-
styrylchromones and styrenes, mediated by palladium catalysts,
in one-pot fashion. The proposed mechanism involves Heck
coupling between brominated chromones and styrenes to form
2,3-distyrylchromones, in situ electrocyclization, [1,5]-sigma-
tropic hydrogen migration to give 3,4-dihydroxanthones and
finally oxidation to achieve the corresponding 2,3-diarylxanth-
ones 103. From this reaction it was also possible to isolate 2,3-
diaryl-3,4-dihydroxanthone intermediates 104 and 6,7-diaryl-1-
hydroxy-9H-xanthen-9-ones 105 when 3-bromo-5-methoxy-
2-styrylchromones were used as brominated derivatives
(Scheme 26).[31,32,69] A few 2,3-diarylxanthone derivatives were
also obtained through one-pot cyclization and oxidation reac-
tions of 2,3-distyrylchromones in 1,2,4-trichlorobenzene at re-
flux.[32]
Scheme 26. One-pot reactions between 2-SCs and styrenes, promoted by
palladium catalysts.
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The synthesis of 6,8-dibromo-5-hydroxy-2-styrylchromones
or 5-hydroxy-6,8-diiodo-2-styrylchromones was achieved
through halogenation of 5-hydroxy-2-styrylchromones with one
equivalent of bromine or iodine, respectively, in DMSO at re-
flux.[52,54] With use of 0.5 equiv. of the halogen, a mixture of
monohalogenated 6- and 8-bromo/iodo derivatives was ob-
tained.[54]
Regioselective epoxidation of 2-SCs with hydrogen peroxide
and iodosylbenzene in the presence of the Jacobsen catalyst
(107) led to the synthesis of a range of α,-epoxy-2-styryl-
chromones 106 (Scheme 27). Although the best results were
accomplished with iodosylbenzene as oxidant, poor yields are
generally obtained, due to the low reactivity of 2-SCs and the
unstable character of the epoxides formed.[111]
Scheme 27. Epoxidation of 2-SCs with hydrogen peroxide and iodosylbenz-
ene in the presence of the Jacobsen catalyst (107).
5. Biological Properties of 2-Styrylchromones
A variety of biological properties have been ascribed to 2-SCs,
including antiallergic,[112] anti-inflammatory,[113] antioxid-
ant,[114–118] antitumor[10–12,36,39,119] and antiviral,[49,58,66] as well
as affinity and selectivity for A3 adenosine receptors,[38] re-
viewed by Gomes et al. in 2010.[120] Here we update the biologi-
cal assessment of 2-SCs, but also describe some studies not
considered in that review. According to the literature available
upon 2010 we thus consider four main topics in this chapter:
antioxidant and anti-inflammatory, antimicrobial, antitumor and
neuroprotective activities.
5.1. Antioxidant and Anti-Inflammatory Activities
Pawar reported the DPPH radical scavenging activity of a range
of substituted 2-SCs 108–116 (Figure 4), which showed signifi-
cant inhibitory activity (60–71 %). However, it is difficult to eval-
uate the importance of these data because no positive control
was used.[42] 2-SC has optimal features to be an excellent anti-
oxidant,[120] so some of us synthesized the new 3-hydroxy-2-
styrylchromones 117–119, bearing catechol moieties in the A
and B rings (Figure 4). The scavenging activity of these com-
pounds against reactive oxygen species (superoxide anion radi-
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cal, hydrogen peroxide, hypochlorous acid, singlet oxygen and
peroxyl radical) and reactive nitrogen species (nitric oxide and
peroxynitrite anion) were structure- and concentration-depen-
dent, with IC50 values in the micromolar range, and in most
cases more efficient than the quercetin used as positive con-
trol.[50]
Figure 4. Structures of 2-SC derivatives 1, 4, 6 and 120–128 possessing anti-
oxidant and anti-inflammatory activities.
During this period, studies of interference by 2-SCs in inflam-
matory pathways proceeded. Three of the twelve tested poly-
hydroxylated 2-SCs 1, 4, 6 and 120–128 (Figure 4) significantly
inhibited NF-kB activation and reduced the production of pro-
inflammatory cytokines/chemokines, with 5,3′,4′-trihydroxy-2-
styrylchromone (6) being the most active compound.[121]
Hormothamnione diacetylated in the B-ring can be used in
the treatment of inflammatory diseases, due to its inhibitory
action on cell–cell adhesion between promyolocytic human
leukaemia-60 (HL-60) cells and Chinese hamster ovary (CHO)
intercellular cell adhesion molecule-1 (ICAM-1) cells.[122]
5.2. Antimicrobial Activity
In the first study on the antibacterial activity of 2-SCs,[72] a se-
ries of fluorinated 2-SCs – compounds 129–138 (Figure 5) –
were prepared. They displayed higher antibacterial activity
against Gram-positive than Gram-negative bacteria, with the ac-
tivity being dependent on the number and position(s) of the
fluorine substituent(s). The efficiency of these compounds fol-
lows the order: Bacillus subtilis more than Staphylococcus aureus
and the single strain of Escherichia coli (ATCC 25922). Moreover,
3′,5′-difluoro-2-styrylchromone (132) was active not only for
E. coli (ATCC 25922) but also for E. coli (ATCC 35218).[72]
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Figure 5. Structures of 2-SC derivatives 1, 4, 116, 120 and 129–153, presenting antimicrobial activity.
Two years later, Nikam et al. evaluated the antibacterial
(S. aureus, B. subtilis, E. coli and Pseudomonas aeruginosa) and
antifungal (Candida albicans, Aspergillus niger and A. flavus) ac-
tivities of 139–146, 2-SCs each bearing a 1,2,4-triazole ring as
substituent at C-4′ (Figure 5).[73] Compounds 139 and 141 pre-
sented excellent activity against C. albicans (MIC 25 μg mL–1) in
comparison with the standard fluconazole (MIC 50 μg mL–1).
Docking studies indicated good binding interaction at the ac-
tive site of fungal enzyme P-450 cytochrome lanosterol 14 α-
demethylase, whereas good pharmacokinetics and drug-like
properties were obtained from ADMET predictions.
A group of 2-SCs bearing substituents at C-3, C-5, C-α and
C-4′ – compounds 4, 116, 120, 136 and 147–153 (Figure 5) –
were screened for antinorovirus activity, together with parent
1. Of these, 5-hydroxy-2-styrylchromone (4) and 4′-methoxy-2-
styrylchromone (136) were the best agents, with IC50 values
around 7 μM. The mechanism of action of these compounds
was also disclosed.[71]
Figure 6. Structures of 2-SC derivatives 154–169 presenting antitumor activity.
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5.3. Antitumor Activity
Natural platachromones A–D 7–10 (Figure 3) possess cytotoxic
activity against human carcinoma cell lines with IC50 values
ranging from 3.0 to 9.7 μM against HepG2 (human hepato-
carcinoma cell line) and KB (human epidermoid carcinoma cell
line), although they are less active than taxol (IC50 0.04–
0.05 μM), used as positive control.[15] Lower sensitivity was ob-
served for SMMC-7721 (human hepatocarcinoma cell line) and
MDA-MB-231 (human breast cancer cell line), with IC50 values
of 14.6–21.3 and 8.7–22.3 μM, respectively.
Lin et al. demonstrated that polymethoxy-2-styrylchromones
154–158 are more active growth inhibitors of several carci-
noma cells, especially gastric carcinoma cells, than their hydrox-
ylated counterparts 159–163 (Figure 6). A common structural
feature is the presence of a 3′,4′,5′-trimethoxy substituent, the
5-methoxylated derivative 154 being the most effective, with
an GI50 value of 1.3 μM. They also showed the importance of
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the Cα=C double bond, reduction of which drastically de-
creased the compounds' growth inhibitory activity.[40]
The four 2-SC-based lavendustin A analogues 164–167
showed good anticancer activity against A-549 (human lung
carcinoma), HCT-15 (human colon cancer cells) and KB cell lines
(Figure 6). Compound 167 showed the highest activity (IC50
9.22 ± 1.8 μg mL–1) against HCT-15, whereas 164 showed good
activity against A-549 and KB cell lines (IC50 17.9 ± 2.9 and
34.98 ± 6.6 μg mL–1, respectively).[37,123] Compound 168 (Fig-
ure 6) is a promising chemopreventive and therapeutic agent;
selective inhibition of leukaemia K562 cell proliferation (IC50
4.5 ± 1.9 μM, after 72 h) was accomplished.[75]
Biochemical studies indicate the potential cancer chemopre-
ventive activity of 3′-allyl-5,7,4′-trimethoxy-2-styrylchromone
169 (Figure 6) due to the induction of cytochrome c release.[124]
5.4. Neuroprotective Activity
The protective effect of natural 6,4′-dihydroxy-3′-methoxy-2-
styrylchromone (5, Figure 3) at 10 μM concentration was tested
against glutamate-induced neurotoxicity in P12 pheochromo-
cytoma cells and corticosterone-induced neurotoxicity in hu-
man U251 glioma cells.[14] The results showed moderate activity
in the former case (58.3 ± 2.8 %) and absence of activity in pre-
venting neurotoxicity in the last cell line tested. For comparison,
the standard fluoxetine showed neuroprotective activity of
92.5 ± 3.2 and 93.7 ± 2.1 % at the same concentration for
glutamate-induced and corticosterone-induced neurotoxicity,
respectively. At the same concentration, the absence of neuro-
protective activity in glutamate-induced neurotoxicity in pri-
mary cultures of rat cortical cells by natural 5-hydroxy-2-styryl-
chromone (4, Figure 3) was also reported.[12] The natural 5,7,4′-
trihydroxy-2-styrylchromone (6, Figure 3) exhibited weak inhibi-
tory activity against acetylcholinesterase with an IC50 value of
78.35 ± 1.15 μM in comparison with the positive control berber-
ine (IC50 0.67 ± 0.02 μM). However, a good inhibitory activity
against butyrylcholinesterase was observed (6 IC50
28.80 ± 1.57 μM; berberine IC50 14.04 ± 1.46 μM) and also
against the -site amyloid precursor protein cleaving enzyme 1
(BACE1, 6 IC50 6.25 ± 0.16 μM; quercetin IC50 26.94 ± 0.10 μM).[16]
Figure 7. Structures of 2-SC derivatives 170–182 possessing neuroprotective activity.
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Several 6-iodinated 2-SCs were synthesized and screened for
their application as in vivo imaging probes of -amyloid pla-
ques in Alzheimer's disease.[70,74] In an in vitro binding assay,
high affinity towards preformed synthetic A (1–40) aggregates
was observed for compounds [125I]170, [125I]171 and [125I]172,
with Kd values of 32.0 ± 5.0, 17.5 ± 2.5 and 8.7 ± 2.7 nM, respec-
tively (Figure 7). In addition, in vivo biodistribution of radioac-
tivity after intravenous administration in normal mice revealed
high initial brain uptake and fast washout from the brain only
for compounds [125I]170 and [125I]171, whereas the slow brain
washout observed for [125I]172 made it unsuitable to be used
as in vivo -amyloid imaging agent.[70]
Years later, a series of other 6-iodinated 2-SCs – compounds
173–180 in Figure 7 – mostly possessing an alkoxy group in
the B-ring were tested in binding affinity assays. The inhibition
constant (Ki) values for the A aggregates varied from 21.9 to
553 nM, with compounds 174, 175 and 180 presenting the
strongest binding interactions. Radioiodinated derivatives 181
and 182 (Figure 7) were prepared and showed high initial brain
uptake and favourable clearance from the brain tissue of nor-
mal mice, in the biodistribution of radioactivity assay. Single-
photon emission computed tomography (SPECT) imaging and
autoradiography helped to identify compound 182 as a more
promising A imaging probe.[74]
Another study was performed to evaluate the potential of
radioiodinated 2-SCs (Figure 7) for SPECT imaging of cerebral
prion deposits. The results indicate that 2-SC 172 exhibited
high in vitro binding affinity (Kd 24.5 nM) and capacity (Bmax =
36.3 pmol/nmol protein) towards recombinant mouse prion
protein aggregates and high accumulation in prion-protein-
positive regions of mouse brain infected with mouse-adapted
bovine spongiform encephalopathy.[125] Moreover, 2-SCs 174
and 175 revealed high binding affinity for recombinant mouse
prion protein aggregates, with Ki values of 20.8 and 26.6 nM,
respectively. The similar radioiodinated derivatives 181 and 182
showed pronounced accumulation in prion-deposit-rich regions
of mouse brain infected with mouse-adapted bovine spongi-
form encephalopathy. SPECT imaging and autoradiography
data indicate that 2-SC 181 might be a potential imaging probe
for monitoring prion deposit levels in the living brain.[125]
Microreview
6. Conclusions
The chemistry of 2-styrylchromones has been known since
1923 and continues to be relevant in the 21st century as a
challenging topic of research in heterocyclic chemistry. Up until
2016, nine derivatives had been isolated from natural sources,
and a huge variety of 2-styrylchromones had been synthesized
by six main protocols, with aldol condensation/cyclodehydro-
genation and Baker–Venkataraman rearrangement representing
the most versatile approaches. Their involvement in photo-
oxidative reactions, cycloadditions, reactions with nucleophiles
and other transformations have been compiled and explored.
A brief examination of the biological properties of 2-styryl-
chromones and structure–activity relationships is also included
in this review.
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